Global DNA & RNA Oligonucleotides Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global DNA & RNA Oligonucleotides market size was valued at USD 1290.3 million in 2023 and is forecast to a readjusted size of USD 1512.6 million by 2030 with a CAGR of 2.3% during review period.

An oligonucleotide is a short chain of DNA or RNA molecules. It is used in molecular biology and medicine as a probe to screen for diseases, viral infections, and to identify genes in molecular biology experiments. It is also used as a primer in a type of DNA sequencing. Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences.

The Global Info Research report includes an overview of the development of the DNA & RNA Oligonucleotides industry chain, the market status of Hospitals and Clinics (DNA Oligonucleotides, RNA Oligonucleotides), Biopharma Companies (DNA Oligonucleotides, RNA Oligonucleotides), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of DNA & RNA Oligonucleotides.

Regionally, the report analyzes the DNA & RNA Oligonucleotides markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global DNA & RNA Oligonucleotides market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the DNA & RNA Oligonucleotides market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the DNA & RNA Oligonucleotides industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., DNA Oligonucleotides, RNA Oligonucleotides).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the DNA & RNA Oligonucleotides market.

Regional Analysis: The report involves examining the DNA & RNA Oligonucleotides market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the DNA & RNA Oligonucleotides market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to DNA & RNA Oligonucleotides:
Company Analysis: Report covers individual DNA & RNA Oligonucleotides players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards DNA & RNA Oligonucleotides This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Clinics, Biopharma Companies).

Technology Analysis: Report covers specific technologies relevant to DNA & RNA Oligonucleotides. It assesses the current state, advancements, and potential future developments in DNA & RNA Oligonucleotides areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the DNA & RNA Oligonucleotides market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
DNA & RNA Oligonucleotides market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    DNA Oligonucleotides
    RNA Oligonucleotides

Market segment by Application
    Hospitals and Clinics
    Biopharma Companies
    Academic & Research Organizations
    Others

Market segment by players, this report covers
    Eurofins Scientific
    Natera
    BGI
    Illumina
    Roche
    LabCorp
    Berry Genomics
    Brooks Life Sciences
    Macrogen
    Genotypic Technology
    Dna Link

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe DNA & RNA Oligonucleotides product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of DNA & RNA Oligonucleotides, with revenue, gross margin and global market share of DNA & RNA Oligonucleotides from 2019 to 2024.
Chapter 3, the DNA & RNA Oligonucleotides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and DNA & RNA Oligonucleotides market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of DNA & RNA Oligonucleotides.
Chapter 13, to describe DNA & RNA Oligonucleotides research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of DNA & RNA Oligonucleotides
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of DNA & RNA Oligonucleotides by Type
        1.3.1 Overview: Global DNA & RNA Oligonucleotides Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global DNA & RNA Oligonucleotides Consumption Value Market Share by Type in 2023
        1.3.3 DNA Oligonucleotides
        1.3.4 RNA Oligonucleotides
    1.4 Global DNA & RNA Oligonucleotides Market by Application
        1.4.1 Overview: Global DNA & RNA Oligonucleotides Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals and Clinics
        1.4.3 Biopharma Companies
        1.4.4 Academic & Research Organizations
        1.4.5 Others
    1.5 Global DNA & RNA Oligonucleotides Market Size & Forecast
    1.6 Global DNA & RNA Oligonucleotides Market Size and Forecast by Region
        1.6.1 Global DNA & RNA Oligonucleotides Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global DNA & RNA Oligonucleotides Market Size by Region, (2019-2030)
        1.6.3 North America DNA & RNA Oligonucleotides Market Size and Prospect (2019-2030)
        1.6.4 Europe DNA & RNA Oligonucleotides Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific DNA & RNA Oligonucleotides Market Size and Prospect (2019-2030)
        1.6.6 South America DNA & RNA Oligonucleotides Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa DNA & RNA Oligonucleotides Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Eurofins Scientific
        2.1.1 Eurofins Scientific Details
        2.1.2 Eurofins Scientific Major Business
        2.1.3 Eurofins Scientific DNA & RNA Oligonucleotides Product and Solutions
        2.1.4 Eurofins Scientific DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Eurofins Scientific Recent Developments and Future Plans
    2.2 Natera
        2.2.1 Natera Details
        2.2.2 Natera Major Business
        2.2.3 Natera DNA & RNA Oligonucleotides Product and Solutions
        2.2.4 Natera DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Natera Recent Developments and Future Plans
    2.3 BGI
        2.3.1 BGI Details
        2.3.2 BGI Major Business
        2.3.3 BGI DNA & RNA Oligonucleotides Product and Solutions
        2.3.4 BGI DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 BGI Recent Developments and Future Plans
    2.4 Illumina
        2.4.1 Illumina Details
        2.4.2 Illumina Major Business
        2.4.3 Illumina DNA & RNA Oligonucleotides Product and Solutions
        2.4.4 Illumina DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Illumina Recent Developments and Future Plans
    2.5 Roche
        2.5.1 Roche Details
        2.5.2 Roche Major Business
        2.5.3 Roche DNA & RNA Oligonucleotides Product and Solutions
        2.5.4 Roche DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Roche Recent Developments and Future Plans
    2.6 LabCorp
        2.6.1 LabCorp Details
        2.6.2 LabCorp Major Business
        2.6.3 LabCorp DNA & RNA Oligonucleotides Product and Solutions
        2.6.4 LabCorp DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 LabCorp Recent Developments and Future Plans
    2.7 Berry Genomics
        2.7.1 Berry Genomics Details
        2.7.2 Berry Genomics Major Business
        2.7.3 Berry Genomics DNA & RNA Oligonucleotides Product and Solutions
        2.7.4 Berry Genomics DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Berry Genomics Recent Developments and Future Plans
    2.8 Brooks Life Sciences
        2.8.1 Brooks Life Sciences Details
        2.8.2 Brooks Life Sciences Major Business
        2.8.3 Brooks Life Sciences DNA & RNA Oligonucleotides Product and Solutions
        2.8.4 Brooks Life Sciences DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Brooks Life Sciences Recent Developments and Future Plans
    2.9 Macrogen
        2.9.1 Macrogen Details
        2.9.2 Macrogen Major Business
        2.9.3 Macrogen DNA & RNA Oligonucleotides Product and Solutions
        2.9.4 Macrogen DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Macrogen Recent Developments and Future Plans
    2.10 Genotypic Technology
        2.10.1 Genotypic Technology Details
        2.10.2 Genotypic Technology Major Business
        2.10.3 Genotypic Technology DNA & RNA Oligonucleotides Product and Solutions
        2.10.4 Genotypic Technology DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Genotypic Technology Recent Developments and Future Plans
    2.11 Dna Link
        2.11.1 Dna Link Details
        2.11.2 Dna Link Major Business
        2.11.3 Dna Link DNA & RNA Oligonucleotides Product and Solutions
        2.11.4 Dna Link DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Dna Link Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global DNA & RNA Oligonucleotides Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of DNA & RNA Oligonucleotides by Company Revenue
        3.2.2 Top 3 DNA & RNA Oligonucleotides Players Market Share in 2023
        3.2.3 Top 6 DNA & RNA Oligonucleotides Players Market Share in 2023
    3.3 DNA & RNA Oligonucleotides Market: Overall Company Footprint Analysis
        3.3.1 DNA & RNA Oligonucleotides Market: Region Footprint
        3.3.2 DNA & RNA Oligonucleotides Market: Company Product Type Footprint
        3.3.3 DNA & RNA Oligonucleotides Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global DNA & RNA Oligonucleotides Consumption Value and Market Share by Type (2019-2024)
    4.2 Global DNA & RNA Oligonucleotides Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global DNA & RNA Oligonucleotides Consumption Value Market Share by Application (2019-2024)
    5.2 Global DNA & RNA Oligonucleotides Market Forecast by Application (2025-2030)

6 North America
    6.1 North America DNA & RNA Oligonucleotides Consumption Value by Type (2019-2030)
    6.2 North America DNA & RNA Oligonucleotides Consumption Value by Application (2019-2030)
    6.3 North America DNA & RNA Oligonucleotides Market Size by Country
        6.3.1 North America DNA & RNA Oligonucleotides Consumption Value by Country (2019-2030)
        6.3.2 United States DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        6.3.3 Canada DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        6.3.4 Mexico DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe DNA & RNA Oligonucleotides Consumption Value by Type (2019-2030)
    7.2 Europe DNA & RNA Oligonucleotides Consumption Value by Application (2019-2030)
    7.3 Europe DNA & RNA Oligonucleotides Market Size by Country
        7.3.1 Europe DNA & RNA Oligonucleotides Consumption Value by Country (2019-2030)
        7.3.2 Germany DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        7.3.3 France DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        7.3.5 Russia DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        7.3.6 Italy DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region
        8.3.1 Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Region (2019-2030)
        8.3.2 China DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.3 Japan DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.4 South Korea DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.5 India DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        8.3.7 Australia DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)

9 South America
    9.1 South America DNA & RNA Oligonucleotides Consumption Value by Type (2019-2030)
    9.2 South America DNA & RNA Oligonucleotides Consumption Value by Application (2019-2030)
    9.3 South America DNA & RNA Oligonucleotides Market Size by Country
        9.3.1 South America DNA & RNA Oligonucleotides Consumption Value by Country (2019-2030)
        9.3.2 Brazil DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        9.3.3 Argentina DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country
        10.3.1 Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Country (2019-2030)
        10.3.2 Turkey DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)
        10.3.4 UAE DNA & RNA Oligonucleotides Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 DNA & RNA Oligonucleotides Market Drivers
    11.2 DNA & RNA Oligonucleotides Market Restraints
    11.3 DNA & RNA Oligonucleotides Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 DNA & RNA Oligonucleotides Industry Chain
    12.2 DNA & RNA Oligonucleotides Upstream Analysis
    12.3 DNA & RNA Oligonucleotides Midstream Analysis
    12.4 DNA & RNA Oligonucleotides Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global DNA & RNA Oligonucleotides Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global DNA & RNA Oligonucleotides Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global DNA & RNA Oligonucleotides Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global DNA & RNA Oligonucleotides Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Eurofins Scientific Company Information, Head Office, and Major Competitors
    Table 6. Eurofins Scientific Major Business
    Table 7. Eurofins Scientific DNA & RNA Oligonucleotides Product and Solutions
    Table 8. Eurofins Scientific DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Eurofins Scientific Recent Developments and Future Plans
    Table 10. Natera Company Information, Head Office, and Major Competitors
    Table 11. Natera Major Business
    Table 12. Natera DNA & RNA Oligonucleotides Product and Solutions
    Table 13. Natera DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Natera Recent Developments and Future Plans
    Table 15. BGI Company Information, Head Office, and Major Competitors
    Table 16. BGI Major Business
    Table 17. BGI DNA & RNA Oligonucleotides Product and Solutions
    Table 18. BGI DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. BGI Recent Developments and Future Plans
    Table 20. Illumina Company Information, Head Office, and Major Competitors
    Table 21. Illumina Major Business
    Table 22. Illumina DNA & RNA Oligonucleotides Product and Solutions
    Table 23. Illumina DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Illumina Recent Developments and Future Plans
    Table 25. Roche Company Information, Head Office, and Major Competitors
    Table 26. Roche Major Business
    Table 27. Roche DNA & RNA Oligonucleotides Product and Solutions
    Table 28. Roche DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Roche Recent Developments and Future Plans
    Table 30. LabCorp Company Information, Head Office, and Major Competitors
    Table 31. LabCorp Major Business
    Table 32. LabCorp DNA & RNA Oligonucleotides Product and Solutions
    Table 33. LabCorp DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. LabCorp Recent Developments and Future Plans
    Table 35. Berry Genomics Company Information, Head Office, and Major Competitors
    Table 36. Berry Genomics Major Business
    Table 37. Berry Genomics DNA & RNA Oligonucleotides Product and Solutions
    Table 38. Berry Genomics DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Berry Genomics Recent Developments and Future Plans
    Table 40. Brooks Life Sciences Company Information, Head Office, and Major Competitors
    Table 41. Brooks Life Sciences Major Business
    Table 42. Brooks Life Sciences DNA & RNA Oligonucleotides Product and Solutions
    Table 43. Brooks Life Sciences DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Brooks Life Sciences Recent Developments and Future Plans
    Table 45. Macrogen Company Information, Head Office, and Major Competitors
    Table 46. Macrogen Major Business
    Table 47. Macrogen DNA & RNA Oligonucleotides Product and Solutions
    Table 48. Macrogen DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Macrogen Recent Developments and Future Plans
    Table 50. Genotypic Technology Company Information, Head Office, and Major Competitors
    Table 51. Genotypic Technology Major Business
    Table 52. Genotypic Technology DNA & RNA Oligonucleotides Product and Solutions
    Table 53. Genotypic Technology DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Genotypic Technology Recent Developments and Future Plans
    Table 55. Dna Link Company Information, Head Office, and Major Competitors
    Table 56. Dna Link Major Business
    Table 57. Dna Link DNA & RNA Oligonucleotides Product and Solutions
    Table 58. Dna Link DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Dna Link Recent Developments and Future Plans
    Table 60. Global DNA & RNA Oligonucleotides Revenue (USD Million) by Players (2019-2024)
    Table 61. Global DNA & RNA Oligonucleotides Revenue Share by Players (2019-2024)
    Table 62. Breakdown of DNA & RNA Oligonucleotides by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 63. Market Position of Players in DNA & RNA Oligonucleotides, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 64. Head Office of Key DNA & RNA Oligonucleotides Players
    Table 65. DNA & RNA Oligonucleotides Market: Company Product Type Footprint
    Table 66. DNA & RNA Oligonucleotides Market: Company Product Application Footprint
    Table 67. DNA & RNA Oligonucleotides New Market Entrants and Barriers to Market Entry
    Table 68. DNA & RNA Oligonucleotides Mergers, Acquisition, Agreements, and Collaborations
    Table 69. Global DNA & RNA Oligonucleotides Consumption Value (USD Million) by Type (2019-2024)
    Table 70. Global DNA & RNA Oligonucleotides Consumption Value Share by Type (2019-2024)
    Table 71. Global DNA & RNA Oligonucleotides Consumption Value Forecast by Type (2025-2030)
    Table 72. Global DNA & RNA Oligonucleotides Consumption Value by Application (2019-2024)
    Table 73. Global DNA & RNA Oligonucleotides Consumption Value Forecast by Application (2025-2030)
    Table 74. North America DNA & RNA Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 75. North America DNA & RNA Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 76. North America DNA & RNA Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 77. North America DNA & RNA Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 78. North America DNA & RNA Oligonucleotides Consumption Value by Country (2019-2024) & (USD Million)
    Table 79. North America DNA & RNA Oligonucleotides Consumption Value by Country (2025-2030) & (USD Million)
    Table 80. Europe DNA & RNA Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 81. Europe DNA & RNA Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 82. Europe DNA & RNA Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 83. Europe DNA & RNA Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 84. Europe DNA & RNA Oligonucleotides Consumption Value by Country (2019-2024) & (USD Million)
    Table 85. Europe DNA & RNA Oligonucleotides Consumption Value by Country (2025-2030) & (USD Million)
    Table 86. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 87. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 88. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 89. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 90. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Region (2019-2024) & (USD Million)
    Table 91. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value by Region (2025-2030) & (USD Million)
    Table 92. South America DNA & RNA Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 93. South America DNA & RNA Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 94. South America DNA & RNA Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 95. South America DNA & RNA Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 96. South America DNA & RNA Oligonucleotides Consumption Value by Country (2019-2024) & (USD Million)
    Table 97. South America DNA & RNA Oligonucleotides Consumption Value by Country (2025-2030) & (USD Million)
    Table 98. Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Type (2019-2024) & (USD Million)
    Table 99. Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Type (2025-2030) & (USD Million)
    Table 100. Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Application (2019-2024) & (USD Million)
    Table 101. Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Application (2025-2030) & (USD Million)
    Table 102. Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Country (2019-2024) & (USD Million)
    Table 103. Middle East & Africa DNA & RNA Oligonucleotides Consumption Value by Country (2025-2030) & (USD Million)
    Table 104. DNA & RNA Oligonucleotides Raw Material
    Table 105. Key Suppliers of DNA & RNA Oligonucleotides Raw Materials
List of Figures
    Figure 1. DNA & RNA Oligonucleotides Picture
    Figure 2. Global DNA & RNA Oligonucleotides Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global DNA & RNA Oligonucleotides Consumption Value Market Share by Type in 2023
    Figure 4. DNA Oligonucleotides
    Figure 5. RNA Oligonucleotides
    Figure 6. Global DNA & RNA Oligonucleotides Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. DNA & RNA Oligonucleotides Consumption Value Market Share by Application in 2023
    Figure 8. Hospitals and Clinics Picture
    Figure 9. Biopharma Companies Picture
    Figure 10. Academic & Research Organizations Picture
    Figure 11. Others Picture
    Figure 12. Global DNA & RNA Oligonucleotides Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global DNA & RNA Oligonucleotides Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Market DNA & RNA Oligonucleotides Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 15. Global DNA & RNA Oligonucleotides Consumption Value Market Share by Region (2019-2030)
    Figure 16. Global DNA & RNA Oligonucleotides Consumption Value Market Share by Region in 2023
    Figure 17. North America DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 18. Europe DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 19. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 20. South America DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 21. Middle East and Africa DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 22. Global DNA & RNA Oligonucleotides Revenue Share by Players in 2023
    Figure 23. DNA & RNA Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 24. Global Top 3 Players DNA & RNA Oligonucleotides Market Share in 2023
    Figure 25. Global Top 6 Players DNA & RNA Oligonucleotides Market Share in 2023
    Figure 26. Global DNA & RNA Oligonucleotides Consumption Value Share by Type (2019-2024)
    Figure 27. Global DNA & RNA Oligonucleotides Market Share Forecast by Type (2025-2030)
    Figure 28. Global DNA & RNA Oligonucleotides Consumption Value Share by Application (2019-2024)
    Figure 29. Global DNA & RNA Oligonucleotides Market Share Forecast by Application (2025-2030)
    Figure 30. North America DNA & RNA Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 31. North America DNA & RNA Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 32. North America DNA & RNA Oligonucleotides Consumption Value Market Share by Country (2019-2030)
    Figure 33. United States DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 34. Canada DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 35. Mexico DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 36. Europe DNA & RNA Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 37. Europe DNA & RNA Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 38. Europe DNA & RNA Oligonucleotides Consumption Value Market Share by Country (2019-2030)
    Figure 39. Germany DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 40. France DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 41. United Kingdom DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 42. Russia DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 43. Italy DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 44. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 45. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 46. Asia-Pacific DNA & RNA Oligonucleotides Consumption Value Market Share by Region (2019-2030)
    Figure 47. China DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 48. Japan DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 49. South Korea DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 50. India DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 51. Southeast Asia DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 52. Australia DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 53. South America DNA & RNA Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 54. South America DNA & RNA Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 55. South America DNA & RNA Oligonucleotides Consumption Value Market Share by Country (2019-2030)
    Figure 56. Brazil DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 57. Argentina DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 58. Middle East and Africa DNA & RNA Oligonucleotides Consumption Value Market Share by Type (2019-2030)
    Figure 59. Middle East and Africa DNA & RNA Oligonucleotides Consumption Value Market Share by Application (2019-2030)
    Figure 60. Middle East and Africa DNA & RNA Oligonucleotides Consumption Value Market Share by Country (2019-2030)
    Figure 61. Turkey DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 62. Saudi Arabia DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 63. UAE DNA & RNA Oligonucleotides Consumption Value (2019-2030) & (USD Million)
    Figure 64. DNA & RNA Oligonucleotides Market Drivers
    Figure 65. DNA & RNA Oligonucleotides Market Restraints
    Figure 66. DNA & RNA Oligonucleotides Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of DNA & RNA Oligonucleotides in 2023
    Figure 69. Manufacturing Process Analysis of DNA & RNA Oligonucleotides
    Figure 70. DNA & RNA Oligonucleotides Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Companies Mentioned

Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Genotypic Technology
Dna Link